{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T17:22:01Z","timestamp":1772558521631,"version":"3.50.1"},"reference-count":31,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T00:00:00Z","timestamp":1681344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Carbohydrate antigen 19-9 (CA 19-9) is a representative tumor marker used for the diagnosis of pancreatic and biliary tract cancers. There are few published research results that can be applied to actual clinical practice for ampullary cancer (AC) alone. This study aimed to demonstrate the relationship between the prognosis of AC and the level of CA 19-9, and to determine the optimal thresholds. Methods: Patients who underwent curative resection (pancreaticoduodenectomy (PD) or pylorus preserving pancreaticoduodenectomy (PPPD)) for AC at the Seoul National University Hospital between January 2000 and December 2017 were enrolled. To determine the optimal cutoff values that could clearly stratify the survival outcome, the conditional inference tree (C-tree) method was used. After obtaining the optimal cutoff values, they were compared to the upper normal clinical limit of 36 U\/mL for CA 19-9. Results In total, 385 patients were enrolled in this study. The median value of the tumor marker CA 19-9 was 18.6 U\/mL. Using the C-tree method, 46 U\/mL was determined to be the optimal cutoff value for CA 19-9. Histological differentiation, N stage, and adjuvant chemotherapy were significant predictors. CA 19-9 36 U\/mL had marginal significance as a prognostic factor. In contrast, the new cutoff value, CA 19-9 46 U\/mL, was found to be a statistically significant prognostic factor (HR: 1.37, p = 0.048). Conclusions: The new cutoff value of CA 19-9 46 U\/mL may be used for evaluating the prognosis of AC. Therefore, it may be an effective indicator for determining treatment strategies such as surgical treatments and adjuvant chemotherapy.<\/jats:p>","DOI":"10.3390\/cancers15082281","type":"journal-article","created":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T01:32:03Z","timestamp":1681435923000},"page":"2281","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Optimal Cutoff Value of Tumor Markers for Prognosis Prediction in Ampullary Cancer"],"prefix":"10.3390","volume":"15","author":[{"given":"Seungho","family":"Lee","sequence":"first","affiliation":[{"name":"Departments of Surgery, Cancer Research Institute, Seoul National University College of Medicine, Seoul 03080, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongbeom","family":"Kim","sequence":"additional","affiliation":[{"name":"Departments of Surgery, Cancer Research Institute, Seoul National University College of Medicine, Seoul 03080, Republic of Korea"},{"name":"Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9339-930X","authenticated-orcid":false,"given":"Heeju","family":"Sohn","sequence":"additional","affiliation":[{"name":"Departments of Surgery, Cancer Research Institute, Seoul National University College of Medicine, Seoul 03080, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3171-2540","authenticated-orcid":false,"given":"Mirang","family":"Lee","sequence":"additional","affiliation":[{"name":"Departments of Surgery, Cancer Research Institute, Seoul National University College of Medicine, Seoul 03080, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyesol","family":"Jung","sequence":"additional","affiliation":[{"name":"Departments of Surgery, Cancer Research Institute, Seoul National University College of Medicine, Seoul 03080, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2255-8390","authenticated-orcid":false,"given":"Youngjae","family":"Jo","sequence":"additional","affiliation":[{"name":"Departments of Surgery, Cancer Research Institute, Seoul National University College of Medicine, Seoul 03080, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0456-7824","authenticated-orcid":false,"given":"Youngmin","family":"Han","sequence":"additional","affiliation":[{"name":"Departments of Surgery, Cancer Research Institute, Seoul National University College of Medicine, Seoul 03080, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wooil","family":"Kwon","sequence":"additional","affiliation":[{"name":"Departments of Surgery, Cancer Research Institute, Seoul National University College of Medicine, Seoul 03080, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Young","family":"Jang","sequence":"additional","affiliation":[{"name":"Departments of Surgery, Cancer Research Institute, Seoul National University College of Medicine, Seoul 03080, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,4,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1002\/jhbp.933","article-title":"Outcomes of 5000 pancreatectomies in Korean single referral center and literature reviews","volume":"29","author":"Byun","year":"2021","journal-title":"J. Hepatobiliary Pancreat. Sci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/jhbp.618","article-title":"Recurrence patterns after pancreaticoduodenectomy for ampullary cancer","volume":"26","author":"Kim","year":"2019","journal-title":"J. Hepatobiliary Pancreat. Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/01.sla.0000167853.04171.bb","article-title":"Clinicopathologic analysis of early ampullary cancers with a focus on the feasibility of ampullectomy","volume":"242","author":"Yoon","year":"2005","journal-title":"Ann. Surg."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3322\/canjclin.38.2.104","article-title":"Tumor markers in cancer diagnosis and prognosis","volume":"38","author":"Virji","year":"1988","journal-title":"CA Cancer J. Clin."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/20014091084218","article-title":"Clinical uses of tumor markers: A critical review","volume":"38","author":"Duffy","year":"2001","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"ref_6","first-page":"241","article-title":"Value of preoperative serum CA 19-9 levels in predicting resectability for pancreatic cancer","volume":"49","author":"Tez","year":"2006","journal-title":"Can. J. Surg."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1007\/s10620-005-2927-8","article-title":"The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis","volume":"50","author":"Levy","year":"2005","journal-title":"Dig. Dis. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ejso.2006.10.004","article-title":"Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer","volume":"33","author":"Goonetilleke","year":"2007","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/jhbp.845","article-title":"Preoperative carbohydrate antigen 19-9 and standard uptake value of positron emission tomography-computed tomography as prognostic markers in patients with pancreatic ductal adenocarcinoma","volume":"29","author":"Moon","year":"2020","journal-title":"J. Hepatobiliary Pancreat. Sci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/bjs.10415","article-title":"Prognostic value of carbohydrate antigen 19-9 in patients undergoing resection of biliary tract cancer","volume":"104","author":"Yamashita","year":"2017","journal-title":"Br. J. Surg."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/978-94-017-7215-0_15","article-title":"CA 19-9: Biochemical and Clinical Aspects","volume":"867","author":"Bottoni","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_12","first-page":"105","article-title":"The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal","volume":"3","author":"Ballehaninna","year":"2012","journal-title":"J. Gastrointest. Oncol."},{"key":"ref_13","first-page":"667","article-title":"The clinical significance of elevated levels of serum CA 19-9","volume":"58","author":"Pavai","year":"2003","journal-title":"Med. J. Malays."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.4240\/wjgs.v13.i11.1338","article-title":"Surgical ampullectomy: A comprehensive review","volume":"13","author":"Scroggie","year":"2021","journal-title":"World J. Gastrointest. Surg."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Hong, S.S., Han, S.S., Kwon, W., Jang, J.Y., Kim, H.J., Cho, C.K., Ahn, K.S., Yang, J.D., Park, Y., and Min, S.K. (2021). Comparison of Oncologic Outcomes between Transduodenal Ampullectomy and Pancreatoduodenectomy in Ampulla of Vater Cancer: Korean Multicenter Study. Cancers, 13.","DOI":"10.3390\/cancers13092038"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.hpb.2018.05.002","article-title":"Definition of an extended minimum level of lymphadenectomy in non-pancreatic periampullary cancer resections","volume":"20","author":"Liu","year":"2018","journal-title":"HPB"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.3390\/curroncol28050293","article-title":"Ampullary Carcinoma: An Overview of a Rare Entity and Discussion of Current and Future Therapeutic Challenges","volume":"28","author":"Rizzo","year":"2021","journal-title":"Curr. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s12094-019-02278-6","article-title":"Adjuvant therapy for true ampullary cancer: A systematic review","volume":"22","author":"Bonet","year":"2020","journal-title":"Clin. Transl. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"101853","DOI":"10.1016\/j.suronc.2022.101853","article-title":"Controversies in the diagnosis and treatment of periampullary tumours","volume":"44","author":"Kurzawa","year":"2022","journal-title":"Surg. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"112","DOI":"10.14694\/EdBook_AM.2014.34.112","article-title":"Ampullary cancer: An overview","volume":"34","author":"Ahn","year":"2014","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"ref_21","first-page":"3011","article-title":"Survival and prognostic factors in pancreatic and ampullary cancer","volume":"34","author":"Lemke","year":"2014","journal-title":"Anticancer Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"239","DOI":"10.5946\/ce.2015.48.3.239","article-title":"Diagnostic Accuracy of the Initial Endoscopy for Ampullary Tumors","volume":"48","author":"Lee","year":"2015","journal-title":"Clin. Endosc."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.2147\/CMAR.S255480","article-title":"Combination of CA19-9 and the Neutrophil-to-Lymphocyte Ratio for the Differential Diagnosis of Gallbladder Carcinoma","volume":"12","author":"Chen","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3748\/wjg.v10.i3.427","article-title":"Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: In comparison with CEA","volume":"10","author":"Qin","year":"2004","journal-title":"World J. Gastroenterol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Kim, M., Kim, H., Han, Y., Sohn, H., Kang, J.S., Kwon, W., and Jang, J.Y. (2021). Prognostic Value of Carcinoembryonic Antigen (CEA) and Carbohydrate Antigen 19-9 (CA 19-9) in Gallbladder Cancer; 65 IU\/mL of CA 19-9 Is the New Cut-Off Value for Prognosis. Cancers, 13.","DOI":"10.3390\/cancers13051089"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/annonc\/mdr561","article-title":"The prognostic and predictive value of serum CA19.9 in pancreatic cancer","volume":"23","author":"Humphris","year":"2012","journal-title":"Ann. Oncol."},{"key":"ref_27","first-page":"1588","article-title":"Clinical value of serum CA19-9 as a prognostic factor for the ampulla of Vater carcinoma","volume":"60","author":"Kurihara","year":"2013","journal-title":"Hepatogastroenterology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S1072-7515(98)00326-3","article-title":"Diagnostic and prognostic values of CA 19-9 and CEA in periampullary cancers","volume":"188","author":"Kau","year":"1999","journal-title":"J. Am. Coll. Surg."},{"key":"ref_29","first-page":"4879","article-title":"Preoperative platelet-lymphocyte ratio is an independent prognostic factor in ampullary carcinoma following pancreaticoduodenectomy","volume":"16","author":"Wang","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejso.2014.09.006","article-title":"High serum CA 19-9 but not tumor size should select patients for staging laparoscopy in radiological resectable pancreas head and peri-ampullary cancer","volume":"41","author":"Alexakis","year":"2015","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1002\/ijc.23907","article-title":"Smoking and serum CA19-9 levels according to Lewis and secretor genotypes","volume":"123","author":"Kawai","year":"2008","journal-title":"Int. J. Cancer"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/8\/2281\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:15:33Z","timestamp":1760123733000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/8\/2281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,13]]},"references-count":31,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["cancers15082281"],"URL":"https:\/\/doi.org\/10.3390\/cancers15082281","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,13]]}}}